Login

PZN -

The PZN number you have entered is invalid.

Are you a doctor or pharmacist?
Feel free to use your DocCheck Login

DE EN

Confirmation needed

The physician treating you needs to have prescribed you BIKTARVY^® for you to access the following content.

Can that be confirmed?

Yes

Physicians are welcome to use the DocCheck Login

Unfortunately this content is not available for you.

Hier geht’s zu #NOCHVIELVOR mit vielen wertvollen und hilfreichen Informationen zu einem Leben mit HIV.

Back

Go to website

Back to Homepage

Working principle:
Composition and mode of action

BIKTARVY® is a single tablet to treat infection with human immunodeficiency virus 1 (HIV-1) in adults, adolescents, and children from the age of 2 with a body weight of at least 14 kg.

Three active substances are combined in BIKTARVY®. They reduce the quantity of virus in the body, ideally to below the limit of detection (HIV-1 RNA < 50 copies/ml). The immune system can then recover and the risk of secondary diseases is decreased.

BIKTARVY® contains three active substances that come from two complementary active substance classes. The combination reduces the viral load by inhibiting the enzymes needed for the HI Virus to multiply.

There are two different dosages of BIKTARVY® tablets that the attending physician will prescribe, depending on the patient’s age and body weight.

Adults, adolescents and children who weigh at least 25 kg:

BIKTARVY® 50 mg/200 mg/25 mg film-coated tablets

For children from the age of 2 who weigh at least 14 kg but less than 25 kg:

BIKTARVY® 30 mg/120 mg/15 mg film-coated tablets

Back to Homepage